Log In
Print
BCIQ
Print
Print this Print this
 

Budesonide rectal foam

Also known as: Budenofalk

  Manage Alerts
Collapse Summary General Information
Company Dr. Falk Pharma GmbH
DescriptionFoam formulation of budesonide, a glucocorticosteroid
Molecular Target Corticoid receptors
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat mild to moderate proctitis or proctosigmoiditis; Treat ulcerative colitis (UC)
Regulatory Designation

U.S. - Standard Review (Treat ulcerative colitis (UC))

Partner

Salix Pharmaceuticals Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today